The Current Ratio as of September 2024 (TTM) for Maravai LifeSciences Holdings, Inc. (MRVI) is 10.00

According to Maravai LifeSciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.00. This represents a change of 4.49% compared to the average of 9.57 of the last 4 quarters.

Maravai LifeSciences Holdings, Inc. (MRVI) Historical Current Ratio (quarterly & annually)

How has MRVI Current Ratio performed in the past?

The mean historical Current Ratio of Maravai LifeSciences Holdings, Inc. over the last ten years is 4.95. The current 10.00 Current Ratio has changed 20.12% with respect to the historical average. Over the past ten years (40 quarters), MRVI's Current Ratio was at its highest in in the March 2024 quarter at 11.32. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Maravai LifeSciences Holdings, Inc. (MRVI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Maravai LifeSciences Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maravai LifeSciences Holdings, Inc. (MRVI) Average Current Ratio

How has MRVI Current Ratio performed in the past?

The current Current Ratio of Maravai LifeSciences Holdings, Inc. (MRVI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Maravai LifeSciences Holdings, Inc. (MRVI) Current Ratio vs. Peers

How is MRVI’s Current Ratio compared to its peers?

Maravai LifeSciences Holdings, Inc.’s Current Ratio is less than Roivant Sciences Ltd. (27.91), greater than Krystal Biotech, Inc. (9.50), less than Prometheus Biosciences, Inc. (37.56), less than Akero Therapeutics, Inc. (24.89), greater than Apellis Pharmaceuticals, Inc. (5.08), greater than Halozyme Therapeutics, Inc. (7.41), less than Agios Pharmaceuticals, Inc. (10.09), greater than Insmed Incorporated (2.71), less than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Ultragenyx Pharmaceutical Inc. (3.54), greater than Alector, Inc. (3.52), greater than Legend Biotech Corporation (4.84), greater than Ascendis Pharma A/S (0.74), less than Cytokinetics, Incorporated (10.39), less than Edgewise Therapeutics, Inc. (30.24), greater than Amicus Therapeutics, Inc. (2.75), greater than Incyte Corporation (1.92), less than Denali Therapeutics Inc. (12.46), greater than argenx SE (8.53), greater than Harmony Biosciences Holdings, Inc. (3.13), greater than Arbutus Biopharma Corporation (6.56), less than Immunovant, Inc. (13.08), greater than Arcutis Biotherapeutics, Inc. (8.46), less than Protagonist Therapeutics, Inc. (13.73),

Build a custom stock screener for Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Maravai LifeSciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Maravai LifeSciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.